Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface

Fibroblast Growth Factor Receptor 3 (FGFR3) Associated with the CD20 Antigen Regulates the Rituximab-induced Proliferation Inhibition in B-cell Lymphoma Cells

(2012) Norihiro Kotani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Rituximab resistance

(2011) Andrew R. Rezvani et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

The future of anti-CD20 monoclonal antibodies: are we making progress?

(2011) W. Alduaij et al.   BLOOD

Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma

(2011) T. S. Lewis et al.   CLINICAL CANCER RESEARCH

CD40-mediated cell death requires TRAF6 recruitment

(2011) Malek Jundi et al.   IMMUNOBIOLOGY

CD40 stimulation sensitizes CLL cells to rituximab-induced cell death

(2011) M Jak et al.   LEUKEMIA

Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC

(2009) Atsushi Inagaki et al.   INTERNATIONAL JOURNAL OF CANCER

CD154 and its receptors in inflammatory vascular pathologies

(2009) Ghada S. Hassan et al.   TRENDS IN IMMUNOLOGY

Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling

(2008) Claire A. Walshe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY